These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 34063031)

  • 1. Some CSF Kynurenine Pathway Intermediates Associated with Disease Evolution in Amyotrophic Lateral Sclerosis.
    Alarcan H; Chaumond R; Emond P; Benz-De Bretagne I; Lefèvre A; Bakkouche SE; Veyrat-Durebex C; Vourc'h P; Andres C; Corcia P; Blasco H
    Biomolecules; 2021 May; 11(5):. PubMed ID: 34063031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The kynurenine pathway and inflammation in amyotrophic lateral sclerosis.
    Chen Y; Stankovic R; Cullen KM; Meininger V; Garner B; Coggan S; Grant R; Brew BJ; Guillemin GJ
    Neurotox Res; 2010 Aug; 18(2):132-42. PubMed ID: 19921535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoaminergic and Kynurenergic Characterization of Frontotemporal Dementia and Amyotrophic Lateral Sclerosis in Cerebrospinal Fluid and Serum.
    Janssens J; Vermeiren Y; van Faassen M; van der Ley C; Kema IP; De Deyn PP
    Neurochem Res; 2020 May; 45(5):1191-1201. PubMed ID: 32130630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebrospinal fluid kynurenines in multiple sclerosis; relation to disease course and neurocognitive symptoms.
    Aeinehband S; Brenner P; Ståhl S; Bhat M; Fidock MD; Khademi M; Olsson T; Engberg G; Jokinen J; Erhardt S; Piehl F
    Brain Behav Immun; 2016 Jan; 51():47-55. PubMed ID: 26189678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent advances in the treatment of amyotrophic lateral sclerosis. Emphasis on kynurenine pathway inhibitors.
    Chen Y; Meininger V; Guillemin GJ
    Cent Nerv Syst Agents Med Chem; 2009 Mar; 9(1):32-9. PubMed ID: 20021336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endogenous protectant kynurenic acid in amyotrophic lateral sclerosis.
    Iłzecka J; Kocki T; Stelmasiak Z; Turski WA
    Acta Neurol Scand; 2003 Jun; 107(6):412-8. PubMed ID: 12757473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kynurenine pathway metabolites in cerebrospinal fluid and blood as potential biomarkers in Huntington's disease.
    Rodrigues FB; Byrne LM; Lowe AJ; Tortelli R; Heins M; Flik G; Johnson EB; De Vita E; Scahill RI; Giorgini F; Wild EJ
    J Neurochem; 2021 Jul; 158(2):539-553. PubMed ID: 33797782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammatory markers in cerebrospinal fluid: independent prognostic biomarkers in amyotrophic lateral sclerosis?
    Gille B; De Schaepdryver M; Dedeene L; Goossens J; Claeys KG; Van Den Bosch L; Tournoy J; Van Damme P; Poesen K
    J Neurol Neurosurg Psychiatry; 2019 Dec; 90(12):1338-1346. PubMed ID: 31175169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implications for the kynurenine pathway and quinolinic acid in amyotrophic lateral sclerosis.
    Guillemin GJ; Meininger V; Brew BJ
    Neurodegener Dis; 2005; 2(3-4):166-76. PubMed ID: 16909022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic Analysis of Tryptophan Metabolism Genes in Sporadic Amyotrophic Lateral Sclerosis.
    Fifita JA; Chan Moi Fat S; McCann EP; Williams KL; Twine NA; Bauer DC; Rowe DB; Pamphlett R; Kiernan MC; Tan VX; Blair IP; Guillemin GJ
    Front Immunol; 2021; 12():701550. PubMed ID: 34194442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of quinolinic acid in the neuropathogenesis of amyotrophic lateral sclerosis.
    Lee JM; Tan V; Lovejoy D; Braidy N; Rowe DB; Brew BJ; Guillemin GJ
    Neuropharmacology; 2017 Jan; 112(Pt B):346-364. PubMed ID: 27265569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biomarker-based predictive models for prognosis in amyotrophic lateral sclerosis.
    Su XW; Simmons Z; Mitchell RM; Kong L; Stephens HE; Connor JR
    JAMA Neurol; 2013 Dec; 70(12):1505-11. PubMed ID: 24145899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measurement of cystatin C levels in the cerebrospinal fluid of patients with amyotrophic lateral sclerosis.
    Ren Y; Zhu W; Cui F; Yang F; Chen Z; Ling L; Huang X
    Int J Clin Exp Pathol; 2015; 8(5):5419-26. PubMed ID: 26191245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different Kynurenine Pathway Dysregulation in Systemic Sclerosis in Men and Women.
    Turska-Kozłowska M; Pedraz-Petrozzi B; Paluszkiewicz P; Parada-Turska J
    Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated levels of ferritin in the cerebrospinal fluid of amyotrophic lateral sclerosis patients.
    Zheng Y; Gao L; Wang D; Zang D
    Acta Neurol Scand; 2017 Aug; 136(2):145-150. PubMed ID: 27804118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kynurenic Acid Levels are Increased in the CSF of Alzheimer's Disease Patients.
    González-Sánchez M; Jiménez J; Narváez A; Antequera D; Llamas-Velasco S; Martín AH; Arjona JAM; Munain AL; Bisa AL; Marco MP; Rodríguez-Núñez M; Pérez-Martínez DA; Villarejo-Galende A; Bartolome F; Domínguez E; Carro E
    Biomolecules; 2020 Apr; 10(4):. PubMed ID: 32276479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rates of progression of weight and forced vital capacity as relevant measurement to adapt amyotrophic lateral sclerosis management for patient Result of a French multicentre cohort survey.
    Clavelou P; Blanquet M; Peyrol F; Ouchchane L; Gerbaud L
    J Neurol Sci; 2013 Aug; 331(1-2):126-31. PubMed ID: 23809193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic and Prognostic Biomarkers in Amyotrophic Lateral Sclerosis: Neurofilament Light Chain Levels in Definite Subtypes of Disease.
    Gaiani A; Martinelli I; Bello L; Querin G; Puthenparampil M; Ruggero S; Toffanin E; Cagnin A; Briani C; Pegoraro E; Sorarù G
    JAMA Neurol; 2017 May; 74(5):525-532. PubMed ID: 28264096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of the kynurenine pathway in NSC-34 cell line: implications for amyotrophic lateral sclerosis.
    Chen Y; Brew BJ; Guillemin GJ
    J Neurochem; 2011 Sep; 118(5):816-25. PubMed ID: 21182524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphorylated neurofilament heavy subunit (pNF-H) in peripheral blood and CSF as a potential prognostic biomarker in amyotrophic lateral sclerosis.
    Boylan KB; Glass JD; Crook JE; Yang C; Thomas CS; Desaro P; Johnston A; Overstreet K; Kelly C; Polak M; Shaw G
    J Neurol Neurosurg Psychiatry; 2013 Apr; 84(4):467-72. PubMed ID: 23117489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.